What is Icometrix?
Icometrix is a Belgian-origin healthcare technology company that leverages artificial intelligence and medical imaging analytics to develop advanced software solutions. Its core focus is on improving the diagnosis, monitoring, and management of neurological disorders by transforming complex brain imaging data into clinically actionable insights. The company's platforms analyze data from MRI and CT scans, extracting quantitative measurements to assist healthcare professionals in making more accurate and timely medical decisions. Positioned as a specialized provider of digital health technologies, icometrix combines expertise in neuroscience, radiology, data science, and AI to offer objective, data-driven approaches to brain imaging interpretation, addressing the complexities of identifying subtle disease progression.
How much funding has Icometrix raised?
Icometrix has raised a total of $20.2M across 2 funding rounds:
Private Equity
$2.2M
Other Financing Round
$18M
Private Equity (2016): $2.2M, investors not publicly disclosed
Other Financing Round (2019): $18M, investors not publicly disclosed
What's next for Icometrix?
With the recent major strategic investment and substantial total capital raised, icometrix is poised for accelerated expansion and further development of its AI-powered diagnostic tools. The company's focus on neurological disorders, a critical area in healthcare, suggests a strategic direction towards deepening its market penetration and potentially broadening its application scope. Future endeavors will likely involve enhancing its software capabilities, forging new partnerships within the healthcare ecosystem, and scaling its operations to meet the growing global demand for advanced medical imaging analysis. This infusion of capital is expected to fuel innovation and solidify icometrix's position as a leader in digital health for neurological care.
See full Icometrix company page
